Annie Estrin Launches Public Awareness Campaign After a Paraiso Miami Swim Week Injury

Fashion journalist launches initiative recognizing healthcare professionals and first responders whose work often goes unseen despite its life-changing impact. MIAMI, June 21, 2026 /PRNewswire/ — Fashion journalist and media contributor Annie Estrin has launched a public awareness…

Annie Estrin Launches Public Awareness Campaign After a Paraiso Miami Swim Week Injury Read More »

Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE

ATG-106 is a first-in-class CDH6 x CD3 bispecific T cell engager (TCE) in preclinical development for the treatment of solid tumors K2 Therapeutics, established by MPM BioImpact, obtains exclusive global rights to develop and commercialize ATG-106 outside Greater China Antengene receives…

Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE Read More »

LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use

INCHEON, South Korea and SAN DIEGO, June 21, 2026 /PRNewswire/ — LOTTE Biologics announced that it has completed major construction and obtained approval for use for Plant 1 at its Songdo Bio Campus in Incheon, South Korea. The milestone was achieved approximately two years after the…

LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use Read More »

Murj® Expands Global Footprint with Commercial Launch in Australia and New Zealand

SYDNEY and AUCKLAND, New Zealand, June 21, 2026 /PRNewswire/ — Murj®, a cardiac device management software company, today announced its official expansion into the Australian market alongside broader availability for New Zealand. Following its exhibition at the recent CSANZ / HRS…

Murj® Expands Global Footprint with Commercial Launch in Australia and New Zealand Read More »

Miyu Yamashita Secures 2026 Meijer LPGA Classic for Simply Give Title as Tournament Raises $1.5 Million to Fight Hunger

Yamashita defeats Lottie Woad on the first playoff hole after a dramatic final-round finish at Blythefield Country Club GRAND RAPIDS, Mich., June 21, 2026 /PRNewswire/ — The 12th Meijer LPGA Classic for Simply Give wrapped up today with Miyu Yamashita claiming the 2026 championship title….

Miyu Yamashita Secures 2026 Meijer LPGA Classic for Simply Give Title as Tournament Raises $1.5 Million to Fight Hunger Read More »

Monster Energy’s Manel Kape Stops Kyoji Horiguchi at UFC Fight Night 279 in Las Vegas

32-Year-Old from Luanda, Angola, Earns TKO Victory and $100,000 Performance of the Night Bonus LAS VEGAS, June 21, 2026 /PRNewswire/ — What a shocker! Monster Energy congratulates MMA athlete Manel Kape on defeating Kyoji Horiguchi at UFC Fight Night 279 in Las Vegas on Saturday night….

Monster Energy’s Manel Kape Stops Kyoji Horiguchi at UFC Fight Night 279 in Las Vegas Read More »

Xinhua Silk Road: Grand Dragon Boat Festival celebration kicks off in Yichang, C China’s Hubei

BEIJING, June 21, 2026 /PRNewswire/ — A grand opening ceremony of a cultural festival and a national dragon boat race (Yichang) to celebrate the Dragon Boat Festival, a traditional Chinese festival associated with the ancient patriotic poet Qu Yuan, kicked off in Yichang, central China’s…

Xinhua Silk Road: Grand Dragon Boat Festival celebration kicks off in Yichang, C China’s Hubei Read More »

CureGene Achieves First Participant Dosed in U.S. Pivotal Trial for Evategrel (CG-0255), a Best-in-Class Antiplatelet Drug, Accelerating Global Commercialization

SHANGHAI, June 20, 2026 /PRNewswire/ — CureGene Pharmaceutical today announced that the first participant has been successfully dosed in the U.S. pivotal clinical trial of Evategrel (CG-0255), its proprietary new-generation best-in-class antiplatelet agent. This milestone marks a…

CureGene Achieves First Participant Dosed in U.S. Pivotal Trial for Evategrel (CG-0255), a Best-in-Class Antiplatelet Drug, Accelerating Global Commercialization Read More »

Scroll to Top
Verified by MonsterInsights